Faron Competitors and Similar CompaniesClear all
Faron's competitors and similar companies include Moleculin Biotech, Werewolf Therapeutics, Shanghai Junshi Biosciences and NeoImmuneTech.
 Faron Faron Pharmaceuticals is a biopharmaceutical company developing treatments for medical conditions with unmet needs. |  Moleculin Biotech Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates. |  Werewolf Therapeutics Werewolf Therapeutics is an oncology biotherapeutics company that develops cancer treatments designed to focus the body’s immune response to selectively target cancer. |  Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases. | ||
Founding Date | Founding Date 2007 | Founding Date 2006 | Founding Date 2017 | Founding Date 2012 | Founding Date 2014 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Turku, FI HQ | Locations Houston, US HQ | Locations Cambridge, US HQ | Locations Shanghai, CN HQ | Locations Rockville, US HQ Pohang, KR Seongnam Si, KR |
Employees | Employees 25 | Employees 176% decrease | Employees 28 | Employees 2,578 | Employees 405% decrease |
Valuation ($) | Valuation ($) 245 m | Valuation ($) 7.5 m | Valuation ($) 118.9 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥2.4b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥466.5m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit €1.3m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit ¥2b (FY, 2025) | Gross profit N/A |
Net income | Net income (€27.3m) (FY, 2025) | Net income ($33.6m) (FY, 2025) | Net income ($60.8m) (FY, 2025) | Net income (¥1b) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 491k | Total funding raised $ 56m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Moleculin Biotech
HQ
Houston, US
Employees
17↓ 6% decrease
Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates.
View companyWerewolf Therapeutics
HQ
Cambridge, US
Employees
28
Werewolf Therapeutics is an oncology biotherapeutics company that develops cancer treatments designed to focus the body’s immune response to selectively target cancer.
View companyShanghai Junshi Biosciences
HQ
Shanghai, CN
Employees
2,578
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
View company
NeoImmuneTech
HQ
Rockville, US
Employees
40↓ 5% decrease
NeoImmuneTech (NIT) is a company that develops immunotherapeutics.
View company